Sheets Smith Wealth Management Trims Holdings in Monsanto (MON)
Sheets Smith Wealth Management trimmed its holdings in shares of Monsanto (NYSE:MON) by 2.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,300 shares of the basic materials company’s stock after selling 500 shares during the quarter. Sheets Smith Wealth Management’s holdings in Monsanto were worth $2,020,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of the business. Bruderman Asset Management LLC acquired a new position in shares of Monsanto in the 2nd quarter worth approximately $116,000. Tower Research Capital LLC TRC lifted its position in shares of Monsanto by 230.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after purchasing an additional 750 shares during the period. Americafirst Capital Management LLC acquired a new position in shares of Monsanto in the 3rd quarter worth approximately $148,000. Fieldpoint Private Securities LLC lifted its position in shares of Monsanto by 100.6% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,575 shares of the basic materials company’s stock worth $186,000 after purchasing an additional 790 shares during the period. Finally, Loews Corp acquired a new position in shares of Monsanto in the 2nd quarter worth approximately $202,000. 75.34% of the stock is currently owned by hedge funds and other institutional investors.
Monsanto (NYSE MON) traded up $0.16 during trading on Friday, hitting $119.70. 2,195,896 shares of the company were exchanged, compared to its average volume of 3,661,145. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 1.05. Monsanto has a 52 week low of $106.97 and a 52 week high of $122.79. The firm has a market cap of $52,690.00, a P/E ratio of 22.13, a PEG ratio of 1.69 and a beta of 1.04.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.80%. Monsanto’s payout ratio is presently 39.93%.
In related news, EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total transaction of $966,735.00. Following the transaction, the executive vice president now owns 56,743 shares in the company, valued at approximately $6,772,277.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Nicole M. Ringenberg sold 7,890 shares of the business’s stock in a transaction on Monday, October 16th. The shares were sold at an average price of $122.25, for a total transaction of $964,552.50. Following the transaction, the vice president now owns 38,600 shares in the company, valued at approximately $4,718,850. The disclosure for this sale can be found here. Insiders have sold a total of 20,310 shares of company stock worth $2,458,328 in the last quarter. 0.70% of the stock is owned by corporate insiders.
A number of research analysts have recently issued reports on MON shares. Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. BMO Capital Markets restated a “buy” rating and issued a $128.00 price target on shares of Monsanto in a research report on Thursday, October 5th. Barclays restated an “equal weight” rating and issued a $124.00 price target (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Macquarie downgraded shares of Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Finally, Jefferies Group restated a “hold” rating and issued a $128.00 price target on shares of Monsanto in a research report on Friday, September 15th. Eleven analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Monsanto has a consensus rating of “Hold” and a consensus target price of $126.40.
TRADEMARK VIOLATION WARNING: “Sheets Smith Wealth Management Trims Holdings in Monsanto (MON)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.thecerbatgem.com/2018/01/12/sheets-smith-wealth-management-trims-holdings-in-monsanto-mon.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related stocks with our FREE daily email newsletter.